CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Rocket Pharmaceuticals (RCKT) Reports Q1 2026 Net Loss of $47.6M

EarningsNegative
AI Analysis

Summary

Rocket Pharmaceuticals reported a net loss of $47.6M for Q1 2026. The earnings release provides limited financial details in this brief announcement.

Importance:3/10
Sentiment:
-0.60
earningsnet lossQ1 2026
Related Companies

Read the original article

Published by yahoo_finance on May 18, 2026 4:50 AM

Read Original